跳至主要内容
临床试验/NCT03149783
NCT03149783Unknown2 期

A Randomized Controlled Trial to Determine if Pre- and Post- Operative Regional Pain Control (Transversus Abdominis Plane Block) With Ropivacaine Versus Placebo Leads to Lower Anesthetic and Narcotic Dosing, and Alters Pain Scores

University of Colorado, Denver1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年2月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
80
试验地点
1
主要终点
Pain Scores

研究概览

简要总结

A randomized controlled trial to determine if pre- and post- operative regional pain control (transversus abdominis plane block) with ropivacaine versus placebo leads to lower anesthetic and narcotic dosing, and alters pain scores.

This study plans to learn more about regional anesthesia and pain control during abdominal surgery. The study will gather data about the effectiveness of continuous catheter infusion of local anesthetic after an abdominal operation. Outcomes include pain scores, IV pain medicine requirements, and delirium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

"Study drug" label of drug

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=50 years.
  • Subjects will be undergoing an elective intra-abdominal or abdominal wall operation, including pelvic operations. Surgery specialties included are general surgery, surgical oncology, urology, gynecology, plastic surgery.

排除标准

  • Subjects with a history of dementia or aphasia, as visual analog scale and confusion assessment will be unreliable.
  • Patients with an epidural or spinal catheter block.
  • Patients who do not speak English so that a language barrier is not confused with VAS scoring or confusion.
  • Patients who are abusing alcohol defined by a high AUDIT score (>8) will be excluded.
  • History of bipolar disorder or a psychotic disorder (such as a psychotic major depression, schizophrenia, schizoaffective disorder, or psychosis in Alzheimer's disease or other dementia).
  • Patients with a documented allergy to ropivacaine or other sodium channel blockers.

研究组 & 干预措施

Ropivacaine

Experimental

Participants will have bilateral TAP catheters placed along with continuous infusion of ropivacaine.

干预措施: Ropivacaine HCL (Drug)

Placebo

Placebo Comparator

Participants will have bilateral TAP catheters placed along with continuous infusion of placebo.

干预措施: sodium chloride (Drug)

结局指标

主要结局

Pain Scores

时间窗: Days 0-7 following the operation

Pain scores from the visual analog scale

次要结局

  • Amount of anesthetic(During the operation)
  • Amount of narcotic administered postoperatively(Days 0-7 postop)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验